LOXO Latest News, Press Relases and Analysis

All

Press Releases

7 years ago - By: Investor's Business Daily - Mentions: TEVA MYL GSK ONCE ...

FDA's Scott Gottlieb Resigns — What's Next For Biotech, Pharma?

7 years ago - By: Investor's Business Daily - Mentions: ONCE

FDA Commissioner Scott Gottlieb Reportedly Resigns Post

7 years ago - By: Investor's Business Daily - Mentions: ACAD NBIX ABBV TAK ...

Why These 2 Biotech Stocks Might Be Next On The Takeover List

7 years ago - By: CNBC - Mentions: LLY TWLO INTU ETSY ...

Cramer: I'm kicking myself for not recommending these stocks

7 years ago - By: Investor's Business Daily - Mentions: CELG BMY LLY ONCE ...

Celgene Tumbles As Second Bristol Shareholder Opposes $74 Billion Merger

7 years ago - By: Investor's Business Daily - Mentions: BMY CELG LLY ONCE ...

Celgene Tumbles As Top Bristol Shareholder Opposes $74 Billion Merger

7 years ago - By: Investor's Business Daily - Mentions: ONCE QURE BOLD SLDB ...

Roche Is Buying Spark — Now These Other Gene Therapy Stocks Are In Play

7 years ago - By: Investor's Business Daily - Mentions: HZNP ZTS LLY EOLS ...

Which Pharmaceutical Stocks Are Outperforming All Other Stocks?

7 years ago - By: Investor's Business Daily - Mentions: ONCE PFE BMRN QURE ...

Roche Will Pay $4.8 Billion For Gene Therapy Firm Spark Therapeutics

7 years ago - By: Investor's Business Daily - Mentions: ONCE PFE BMRN QURE ...

Roche Will Pay $4.8 Billion To Buy Gene Therapy Firm Spark Therapeutics

7 years ago - By: Investor's Business Daily - Mentions: ONCE PFE BMRN QURE ...

Roche Reportedly Near $5 Billion Takeover Of Gene Therapy Firm Spark

7 years ago - By: Investor's Business Daily - Mentions: GILD AMGN BIIB CELG ...

The Top 5 Biotech Stocks Are Facing Growth Challenges — Are Any Immune?

7 years ago - By: Benzinga - Mentions: CELG BMY LLY MRK ...

Merck To Buy Immune Design For $300M

7 years ago - By: Barron's - Mentions: BMY BMY CELG LLY ...

Big Pharma Can’t Resist Big Mergers. Here’s Why.

7 years ago - By: Eli Lilly and Company - Mentions: LLY

Lilly Completes Acquisition of Loxo Oncology

7 years ago - By: TalkMarkets - Mentions: XBI BMY CELG LLY ...

5 Tiny Biotech Stocks With Superb Growth Potential

7 years ago - By: Barron's - Mentions: BMY CELG LLY GILD ...

Big Pharma Wants to Borrow Cash for M&A, but Could Run Into Credit Downgrades

7 years ago - By: Investor's Business Daily - Mentions: LLY GSK MYL PFE

This Top Pharma Stock Undercut A Buy Point On Its Earnings Lag

7 years ago - By: Barron's - Mentions: LLY LLY LLY LLY ...

Eli Lilly Stock Falls Because 2019 Doesn’t Look as Good

7 years ago - By: The Street - Mentions: GM DIS GM LLY ...

Dow Falls as Wall Street Gets No Boost From State of the Union

7 years ago - By: Investor's Business Daily - Mentions: LLY GSK MYL PFE

Eli Lilly Earnings Miss, Forecast Light; Stock Flirts With Buy Point

7 years ago - By: Investor's Business Daily - Mentions: LLY GSK

Eli Lilly Earnings Miss, EPS Guidance Light; Stock Threatens To Undercut Buy Point

7 years ago - By: The Street - Mentions: LLY LLY LLY LLY ...

Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal

7 years ago - By: InvestorPlace - Mentions: XBI LLY BMY CELG ...

5 of the Best Biotech Stocks to Buy Now

7 years ago - By: Benzinga - Mentions: AMRN CELG BMY GSK ...

Pharma Catches Another Case Of M&A Fever

7 years ago - By: Eli Lilly and Company - Mentions: LLY

Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed Transaction

7 years ago - By: Investor's Business Daily - Mentions: MRK

Loxo Oncology Inc. (LOXO) Stock News

LOXO Latest News, Press Relases and Analysis

FDA's Scott Gottlieb Resigns — What's Next For Biotech, Pharma?

FDA Commissioner Scott Gottlieb Reportedly Resigns Post

Why These 2 Biotech Stocks Might Be Next On The Takeover List

Cramer: I'm kicking myself for not recommending these stocks

Celgene Tumbles As Second Bristol Shareholder Opposes $74 Billion Merger

Celgene Tumbles As Top Bristol Shareholder Opposes $74 Billion Merger

Roche Is Buying Spark — Now These Other Gene Therapy Stocks Are In Play

Which Pharmaceutical Stocks Are Outperforming All Other Stocks?

Roche Will Pay $4.8 Billion For Gene Therapy Firm Spark Therapeutics

Roche Will Pay $4.8 Billion To Buy Gene Therapy Firm Spark Therapeutics

Roche Reportedly Near $5 Billion Takeover Of Gene Therapy Firm Spark

The Top 5 Biotech Stocks Are Facing Growth Challenges — Are Any Immune?

Merck To Buy Immune Design For $300M

Big Pharma Can’t Resist Big Mergers. Here’s Why.

Lilly Completes Acquisition of Loxo Oncology

5 Tiny Biotech Stocks With Superb Growth Potential

Big Pharma Wants to Borrow Cash for M&A, but Could Run Into Credit Downgrades

This Top Pharma Stock Undercut A Buy Point On Its Earnings Lag

Eli Lilly Stock Falls Because 2019 Doesn’t Look as Good

Dow Falls as Wall Street Gets No Boost From State of the Union

Eli Lilly Earnings Miss, Forecast Light; Stock Flirts With Buy Point

Eli Lilly Earnings Miss, EPS Guidance Light; Stock Threatens To Undercut Buy Point

Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal

5 of the Best Biotech Stocks to Buy Now

Pharma Catches Another Case Of M&A Fever

Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed Transaction

This Pharma Stock Broke Out On Its Merck-Partnered Cancer Regimen